For example, obesity–insulin connections have been considered as potential risk factors for postmenopausal breast cancer, and the association between insulin resistances (IR) genotypes and phenotypes can be modified by obesity-lifestyle factors, affecting breast cancer risk. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.